Cellebrite DI Ltd. (CLBT) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 84.2% | 14.0% | 16.5% |
| 2024 | 84.4% | 14.2% | -70.5% |
| 2023 | 83.6% | 10.2% | -24.9% |
| 2022 | 81.3% | 0.4% | 44.6% |
| 2021 | 82.7% | 5.6% | 29.0% |
Download Data
Export CLBT earnings history in CSV or JSON format
Free sign-in required to download data
Cellebrite DI Ltd. (CLBT) Earnings Overview
As of March 2, 2026, Cellebrite DI Ltd. (CLBT) reported trailing twelve-month net income of $78M, reflecting +1.2% year-over-year growth. The company earned $0.31 per diluted share over the past four quarters, with a net profit margin of 0.2%.
Looking at the long-term picture, CLBT's 5-year EPS compound annual growth rate (CAGR) stands at +58.6%, indicating exceptional earnings growth. The company achieved its highest annual net income of $121M in fiscal 2022.
Cellebrite DI Ltd. maintains positive profitability with a gross margin of 0.8%, operating margin of 0.1%, and net margin of 0.2%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including PLTR ($1.63B net income, 0.4% margin), MDB (-$71M net income, -0.1% margin), IOT (-$42M net income, -0.1% margin), CLBT has room to improve margins relative to the peer group. Compare CLBT vs PLTR →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $78M | +127.7% | $66M | $0.31 | 16.5% | 14.0% |
| 2024 | -$283M | -249.0% | $57M | $-1.35 | -70.5% | 14.2% |
| 2023 | -$81M | -167.1% | $33M | $-0.43 | -24.9% | 10.2% |
| 2022 | $121M | +69.2% | $1M | $0.59 | 44.6% | 0.4% |
| 2021 | $71M | +1135.0% | $14M | $0.44 | 29.0% | 5.6% |
| 2020 | $6M | +408.2% | $9M | $0.03 | 3.0% | 4.7% |
| 2019 | -$2M | - | -$2M | $-0.01 | -1.1% | -0.9% |
See CLBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLBT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CLBT vs NVDA
See how CLBT stacks up against sector leader NVIDIA Corporation.
Start ComparisonFrequently Asked Questions
Is CLBT growing earnings?
CLBT EPS of $0.31 reflects slowing growth at +1.2%, below the 5-year CAGR of +58.6%. TTM net income is $78M. Expansion rate has moderated.
What are CLBT's profit margins?
Cellebrite DI Ltd. net margin is +0.2%, with operating margin at +0.1%. Below-average margins reflect competitive or cost pressures.
How consistent are CLBT's earnings?
CLBT earnings data spans 2019-2025. The current earnings trend is +1.2% YoY. Historical data enables comparison across business cycles.